{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:59:27Z","timestamp":1760237967961,"version":"build-2065373602"},"reference-count":46,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T00:00:00Z","timestamp":1657324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Institutes of Health\/National Eye Institute","doi-asserted-by":"publisher","award":["R01EY015130","R01EY017011","F30EY032311","R01EY024998","P30EY014800"],"award-info":[{"award-number":["R01EY015130","R01EY017011","F30EY032311","R01EY024998","P30EY014800"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Institutes of Health Core Grant","doi-asserted-by":"publisher","award":["R01EY015130","R01EY017011","F30EY032311","R01EY024998","P30EY014800"],"award-info":[{"award-number":["R01EY015130","R01EY017011","F30EY032311","R01EY024998","P30EY014800"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Unrestricted Grant from Research to Prevent Blindness","award":["R01EY015130","R01EY017011","F30EY032311","R01EY024998","P30EY014800"],"award-info":[{"award-number":["R01EY015130","R01EY017011","F30EY032311","R01EY024998","P30EY014800"]}]},{"name":"Steele Center for Translational Medicine","award":["R01EY015130","R01EY017011","F30EY032311","R01EY024998","P30EY014800"],"award-info":[{"award-number":["R01EY015130","R01EY017011","F30EY032311","R01EY024998","P30EY014800"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Erythropoietin (EPO) has been proposed to reduce the progression of atrophic age-related macular degeneration (AMD) due to its potential role in neuroprotection. However, overactive EPO receptor (EPOR) signaling increased laser-induced choroidal neovascularization (CNV) and choroidal macrophage number in non-lasered mice, which raised the question of whether EPOR signaling increased CNV through the recruitment of macrophages to the choroid that released pro-angiogenic factors or through direct angiogenic effects on endothelial cells. In this study, we addressed the hypothesis that EPOR signaling increased CNV by direct effects on macrophages or endothelial cells. We used tamoxifen-inducible macrophage-specific or endothelial cell-specific EPOR knockout mice in the laser-induced CNV model, and cultured choroidal endothelial cells isolated from adult human donors. We found that macrophage-specific knockout of EPOR influenced laser-induced CNV in females only, whereas endothelial-specific knockout of EPOR reduced laser-induced CNV in male mice only. In cultured human choroidal endothelial cells, knockdown of EPOR reduced EPO-induced signal transducer and activator of transcription 3 (STAT3) activation. Taken together, our findings suggest that EPOR signaling in macrophages or choroidal endothelial cells regulates the development of CNV in a sex-dependent manner. Further studies regarding the role of EPO-induced signaling are required to assess EPO safety and to select or develop appropriate therapeutic approaches.<\/jats:p>","DOI":"10.3390\/biomedicines10071655","type":"journal-article","created":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T21:19:28Z","timestamp":1657487968000},"page":"1655","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of Erythropoietin Receptor Signaling in Macrophages or Choroidal Endothelial Cells in Choroidal Neovascularization"],"prefix":"10.3390","volume":"10","author":[{"given":"Aniket","family":"Ramshekar","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, 65 Mario Capecchi Dr, Salt Lake City, UT 84132, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin A.","family":"Bretz","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, 65 Mario Capecchi Dr, Salt Lake City, UT 84132, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0960-5324","authenticated-orcid":false,"given":"Eric","family":"Kunz","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, 65 Mario Capecchi Dr, Salt Lake City, UT 84132, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thaonhi","family":"Cung","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, 65 Mario Capecchi Dr, Salt Lake City, UT 84132, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1789-2335","authenticated-orcid":false,"given":"Burt T.","family":"Richards","sequence":"additional","affiliation":[{"name":"Sharon Eccles Steele Center for Translational Medicine, John A. Moran Eye Center, University of Utah, 65 Mario Capecchi Dr, Salt Lake City, UT 84132, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory J.","family":"Stoddard","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Utah, 30 N 1900 E, Salt Lake City, UT 84132, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory S.","family":"Hageman","sequence":"additional","affiliation":[{"name":"Sharon Eccles Steele Center for Translational Medicine, John A. Moran Eye Center, University of Utah, 65 Mario Capecchi Dr, Salt Lake City, UT 84132, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8516-4324","authenticated-orcid":false,"given":"Brahim","family":"Chaqour","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Pennsylvania, 422 Curie Boulevard, Philadelphia, PA 19104, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Elizabeth","family":"Hartnett","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, 65 Mario Capecchi Dr, Salt Lake City, UT 84132, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob. Health"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ophtha.2017.08.038","article-title":"The Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration","volume":"125","author":"Fleckenstein","year":"2018","journal-title":"Ophthalmology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41572-021-00265-2","article-title":"Age-related macular degeneration","volume":"7","author":"Fleckenstein","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"21093","DOI":"10.1038\/s41598-020-78059-x","article-title":"Macular retinal thickness differs markedly in age-related macular degeneration driven by risk polymorphisms on chromosomes 1 and 10","volume":"10","author":"Zouache","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"108641","DOI":"10.1016\/j.exer.2021.108641","article-title":"N-retinylidene-N-retinylethanolamine adduct induces expression of chronic inflammation cytokines in retinal pigment epithelium cells","volume":"209","author":"Scimone","year":"2021","journal-title":"Exp. Eye Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ophtha.2018.08.035","article-title":"Macular Morphology and Visual Acuity in Year Five of the Comparison of Age-related Macular Degeneration Treatments Trials","volume":"126","author":"Jaffe","year":"2019","journal-title":"Ophthalmology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.mehy.2008.09.055","article-title":"Erythropoietin as a novel therapeutic agent for atrophic age-related macular degeneration","volume":"72","author":"Wang","year":"2009","journal-title":"Med. Hypotheses"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1056\/NEJMcibr022629","article-title":"Erythropoietin\u2014An Endogenous Retinal Survival Factor","volume":"347","author":"Becerra","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.1167\/iovs.07-0093","article-title":"Circulating hematopoietic stem cells in patients with neovascular age-related macular degeneration","volume":"48","author":"Yodoi","year":"2007","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1038\/s41598-018-20520-z","article-title":"Erythropoietin Signaling Increases Choroidal Macrophages and Cytokine Expression, and Exacerbates Choroidal Neovascularization","volume":"8","author":"Bretz","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/sj.ki.5001546","article-title":"Discovering erythropoietin\u2019s extra-hematopoietic functions: Biology and clinical promise","volume":"70","author":"Brines","year":"2006","journal-title":"Kidney Int."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1043-2760(98)00101-5","article-title":"The Erythropoietin Receptor: Structure, Activation and Intracellular Signal Transduction","volume":"10","author":"Constantinescu","year":"1999","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/eye.2016.94","article-title":"Revisiting the role of erythropoietin for treatment of ocular disorders","volume":"30","author":"Leow","year":"2016","journal-title":"Eye"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nm723","article-title":"HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration","volume":"8","author":"Grimm","year":"2002","journal-title":"Nat. Med."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Shah, S.S., Tsang, S.H., and Mahajan, V.B. (2009). Erythropoetin receptor expression in the human diabetic retina. BMC Res. Notes, 2.","DOI":"10.1186\/1756-0500-2-234"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3389\/fimmu.2014.00523","article-title":"Evidence That Erythropoietin Modulates Neuroinflammation through Differential Action on Neurons, Astrocytes, and Microglia","volume":"5","author":"Bond","year":"2014","journal-title":"Front. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0092-8674(95)90234-1","article-title":"Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor","volume":"83","author":"Wu","year":"1995","journal-title":"Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"9126","DOI":"10.1073\/pnas.93.17.9126","article-title":"Thrombopoietin rescues in vitro erythroid colony formation from mouse embryos lacking the erythropoietin receptor","volume":"93","author":"Kieran","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1073\/pnas.98.3.986","article-title":"Mouse model of congenital polycythemia: Homologous replacement of murine gene by mutant human erythropoietin receptor gene","volume":"98","author":"Divoky","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1167\/iovs.61.10.23","article-title":"Signaling Through the Erythropoietin Receptor Affects Angiogenesis in Retinovascular Disease","volume":"61","author":"Bretz","year":"2020","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ajpath.2019.11.009","article-title":"Erythropoietin Receptor Signaling Supports Retinal Function after Vascular Injury","volume":"190","author":"Bretz","year":"2020","journal-title":"Am. J. Pathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.1167\/iovs.13-12289","article-title":"Survey of common eye diseases in laboratory mouse strains","volume":"54","author":"Chang","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/nprot.2013.135","article-title":"Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice","volume":"8","author":"Lambert","year":"2013","journal-title":"Nat. Protoc."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e21642","DOI":"10.1096\/fj.202100112R","article-title":"Active Rap1-mediated inhibition of choroidal neovascularization requires interactions with IQGAP1 in choroidal endothelial cells","volume":"35","author":"Ramshekar","year":"2021","journal-title":"FASEB J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: An open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/gm315","article-title":"Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networks","volume":"4","author":"Newman","year":"2012","journal-title":"Genome Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"24100","DOI":"10.1073\/pnas.1914143116","article-title":"Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration","volume":"116","author":"Voigt","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"108204","DOI":"10.1016\/j.exer.2020.108204","article-title":"Spectacle: An interactive resource for ocular single-cell RNA sequencing data analysis","volume":"200","author":"Voigt","year":"2020","journal-title":"Exp. Eye Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Voigt, A.P., Mullin, N.K., Mulfaul, K., Lozano, L.P., Wiley, L.A., Flamme-Wiese, M.J., Boese, E.A., Han, I.C., Scheetz, T.E., and Stone, E.M. (2022). Choroidal Endothelial and Macrophage Gene Expression in Atrophic and Neovascular Macular Degeneration. Hum. Mol. Genet.","DOI":"10.1093\/hmg\/ddac043"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1182\/blood-2009-10-248666","article-title":"Functional erythropoietin receptor is undetectable in endothelial, cardiac, neuronal, and renal cells","volume":"115","author":"Sinclair","year":"2010","journal-title":"Blood"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.ajpath.2013.12.023","article-title":"VEGFA activates erythropoietin receptor and enhances VEGFR2-mediated pathological angiogenesis","volume":"184","author":"Yang","year":"2014","journal-title":"Am. J. Pathol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000085730","article-title":"Activated STAT3 in choroidal neovascular membranes of patients with age-related macular degeneration","volume":"219","author":"Wunderlich","year":"2005","journal-title":"Ophthalmologica"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ophtha.2019.11.016","article-title":"Incidence of Macular Atrophy after Untreated Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study Report 40","volume":"127","author":"Christakis","year":"2020","journal-title":"Ophthalmology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1001\/jamaophthalmol.2020.0437","article-title":"Incidence and Progression of Nongeographic Atrophy in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Clinical Trial","volume":"138","author":"Daniel","year":"2020","journal-title":"JAMA Ophthalmol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.ophtha.2016.03.045","article-title":"Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials","volume":"123","author":"Maguire","year":"2016","journal-title":"Ophthalmology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.ophtha.2020.03.020","article-title":"Long-term Visual Outcomes after Release from Protocol in Patients who Participated in the Inhibition of VEGF in Age-related Choroidal Neovascularisation (IVAN) Trial","volume":"127","author":"Evans","year":"2020","journal-title":"Ophthalmology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1681\/ASN.2020111638","article-title":"Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES Study","volume":"33","author":"Fishbane","year":"2022","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.3324\/haematol.2010.025015","article-title":"Macrophages as novel target cells for erythropoietin","volume":"95","author":"Lifshitz","year":"2010","journal-title":"Haematologica"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0002-9440(10)63459-1","article-title":"A novel role for erythropoietin during fibrin-induced wound-healing response","volume":"163","author":"Haroon","year":"2003","journal-title":"Am. J. Pathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1182\/blood.2021011410","article-title":"EpoR-tdTomato-Cre mice enable identification of EpoR expression in subsets of tissue macrophages and hematopoietic cells","volume":"138","author":"Zhang","year":"2021","journal-title":"Blood"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cellimm.2016.05.004","article-title":"Erythropoietin increases macrophage-mediated T cell suppression","volume":"306\u2013307","author":"Wood","year":"2016","journal-title":"Cell. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/cvr\/cvu180","article-title":"Erythropoietin priming improves the vasculogenic potential of G-CSF mobilized human peripheral blood mononuclear cells","volume":"104","author":"Kang","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1073\/pnas.91.9.3974","article-title":"Erythropoietin receptor mRNA expression in human endothelial cells","volume":"91","author":"Anagnostou","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Kimakova, P., Solar, P., Solarova, Z., Komel, R., and Debeljak, N. (2017). Erythropoietin and Its Angiogenic Activity. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18071519"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.2353\/ajpath.2007.061018","article-title":"Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularization","volume":"170","author":"Nagai","year":"2007","journal-title":"Am. J. Pathol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Biswal, M.R., Wang, Z., Paulson, R.J., Uddin, R.R., Tong, Y., Zhu, P., Li, H., and Lewin, A.S. (2021). Erythropoietin Gene Therapy Delays Retinal Degeneration Resulting from Oxidative Stress in the Retinal Pigment Epithelium. Antioxidants, 10.","DOI":"10.3390\/antiox10060842"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/7\/1655\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:47:14Z","timestamp":1760140034000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/7\/1655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,9]]},"references-count":46,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["biomedicines10071655"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10071655","relation":{},"ISSN":["2227-9059"],"issn-type":[{"type":"electronic","value":"2227-9059"}],"subject":[],"published":{"date-parts":[[2022,7,9]]}}}